1. Home
  2. Analysis
  3. Ceftazidime
  4. Toxic-encephalopathy

Ceftazidime and Toxic encephalopathy - a phase IV clinical study of FDA data

Summary:

Toxic encephalopathy is reported as a side effect among people who take Ceftazidime (ceftazidime), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Ondansetron, and have Central nervous system leukaemia.

The phase IV clinical study analyzes which people have Toxic encephalopathy when taking Ceftazidime. It is created by eHealthMe based on reports of 10,307 people who have side effects when taking Ceftazidime from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Toxic encephalopathy?

Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances) is found to be associated with 424 drugs and 616 conditions by eHealthMe. Check the latest studies of Toxic encephalopathy.

On Jul, 26, 2026

10,307 people reported to have side effects when taking Ceftazidime.
Among them, 22 people (0.21%) have Toxic encephalopathy.

Could Ceftazidime cause Toxic encephalopathy?

Among these 22 people:

How long have people been on Ceftazidime when they have Toxic encephalopathy? *

  • < 1 month: 87.5 %
  • 1 - 6 months: 12.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Toxic encephalopathy when taking Ceftazidime? *

  • female: 20 %
  • male: 80 %

What is the age of people who have Toxic encephalopathy when taking Ceftazidime? *

  • 0-1: 0.0 %
  • 2-9: 11.11 %
  • 10-19: 44.44 %
  • 20-29: 0.0 %
  • 30-39: 5.56 %
  • 40-49: 5.56 %
  • 50-59: 5.56 %
  • 60+: 27.78 %

What are other drugs people take besides Ceftazidime? *

  1. Ondansetron: 9 people, 40.91%
  2. Vyxeos: 7 people, 31.82%
  3. Lorazepam: 4 people, 18.18%
  4. Metoclopramide: 3 people, 13.64%
  5. Hydrocortisone Sodium Succinate: 3 people, 13.64%
  6. Zovirax: 3 people, 13.64%
  7. Vfend: 3 people, 13.64%
  8. Carmustine: 2 people, 9.09%
  9. Carvedilol: 2 people, 9.09%
  10. Cellcept: 2 people, 9.09%

What are other side effects people have besides Toxic encephalopathy? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 40.91%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 13.64%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 13.64%
  4. Nausea (feeling of having an urge to vomit): 3 people, 13.64%
  5. Overdose: 2 people, 9.09%
  6. Encephalitis Herpes (inflammation of the brain due to herpes infection): 2 people, 9.09%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 9.09%
  8. Dizziness: 2 people, 9.09%
  9. Depressed Level Of Consciousness: 2 people, 9.09%
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 9.09%

What are the existing conditions these people have? *

  1. Central Nervous System Leukaemia (cancer of central nervous system): 9 people, 40.91%
  2. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 9.09%
  3. Urinary Tract Infection Enterococcal: 1 person, 4.55%
  4. Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 1 person, 4.55%
  5. Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 1 person, 4.55%
  6. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 4.55%
  7. Klebsiella Infection: 1 person, 4.55%
  8. Infection: 1 person, 4.55%
  9. High Blood Pressure: 1 person, 4.55%
  10. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and have Toxic encephalopathy?

- Check whether Toxic encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftazidime:

Toxic encephalopathy treatments and more:

How severe was Toxic encephalopathy and when was it recovered:

Expand to all the drugs that have ingredients of ceftazidime:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toxic encephalopathy:

Browse all the conditions that are associated with Toxic encephalopathy:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Ceftazidime) and Ceftazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.